
CCAP Stock Forecast & Price Target
CCAP Analyst Ratings
Bulls say
Crescent Capital BDC reported a significant net growth of $27 million, surpassing expectations of $10 million, indicating a robust performance relative to forecasts. Additionally, the decline in KBW watchlist investments to 1.2% from 3.1% of cost suggests an improvement in the overall credit quality of the portfolio. Although there was an increase in non-accruals and investments rated below expectations, the positive net growth and improved metrics related to watchlist investments contribute to an optimistic outlook for the company.
Bears say
Crescent Capital BDC's net asset value (NAV) experienced a decline of $0.36, or 1.8%, falling to $19.62, primarily due to net portfolio losses and operating earnings that were insufficient to cover dividends paid. The company faces significant risk factors, particularly related to credit issues that could exceed expectations, further threatening its earnings, book value, and stock price. Although total non-accruals are currently at a manageable level of 3.3% at cost value, the rapid deterioration of several recent non-accruals raises concerns about the overall stability of the company's investment portfolio.
This aggregate rating is based on analysts' research of Crescent Capital BDC Inc and is not a guaranteed prediction by Public.com or investment advice.
CCAP Analyst Forecast & Price Prediction
Start investing in CCAP
Order type
Buy in
Order amount
Est. shares
0 shares